Quadrant Capital Group LLC Takeda Pharmaceutical CO LTD Transaction History

Quadrant Capital Group LLC

  • $3 Billion
  • Q3 2025

A detailed history of Quadrant Capital Group LLC transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Quadrant Capital Group LLC holds 47,783 shares of TAK stock, worth $682,819. This represents 0.02% of its overall portfolio holdings.

Number of Shares
47,783
Previous 127,721 62.59%
Holding current value
$682,819
Previous $1.97 Million 64.59%
% of portfolio
0.02%
Previous 0.07%

Shares

34 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 13, 2025
SELL
$13.6 - $15.52 $1.09 Million - $1.24 Million
-79,938 Reduced 62.59%
47,783 $699,000
Q2 2025

Aug 12, 2025
SELL
$13.71 - $15.46 $469,690 - $529,644
-34,259 Reduced 21.15%
127,721 $1.97 Million
Q1 2025

May 13, 2025
BUY
$12.89 - $15.19 $1.85 Million - $2.18 Million
143,774 Added 789.71%
161,980 $2.41 Million
Q4 2024

Feb 12, 2025
BUY
$13.01 - $14.43 $85,800 - $95,165
6,595 Added 56.8%
18,206 $241,000
Q3 2024

Nov 12, 2024
BUY
$13.0 - $15.08 $26,637 - $30,898
2,049 Added 21.43%
11,611 $164,000
Q2 2024

Aug 12, 2024
SELL
$12.6 - $13.67 $70,068 - $76,018
-5,561 Reduced 36.77%
9,562 $123,000
Q1 2024

May 15, 2024
SELL
$13.89 - $15.04 $29,169 - $31,584
-2,100 Reduced 12.19%
15,123 $210,000
Q4 2023

Feb 08, 2024
SELL
$13.36 - $15.43 $33,480 - $38,667
-2,506 Reduced 12.7%
17,223 $245,000
Q3 2023

Nov 14, 2023
SELL
$15.03 - $16.32 $66,823 - $72,558
-4,446 Reduced 18.39%
19,729 $305,000
Q2 2023

Aug 09, 2023
SELL
$15.57 - $17.11 $44,000 - $48,352
-2,826 Reduced 10.47%
24,175 $379,000
Q1 2023

May 11, 2023
BUY
$15.28 - $16.48 $122,866 - $132,515
8,041 Added 42.41%
27,001 $444,000
Q4 2022

Feb 10, 2023
SELL
$12.42 - $15.62 $1,776 - $2,233
-143 Reduced 0.75%
18,960 $295,000
Q3 2022

Nov 10, 2022
BUY
$12.8 - $28.65 $15,539 - $34,781
1,214 Added 6.79%
19,103 $248,000
Q2 2022

Aug 09, 2022
SELL
$13.12 - $15.03 $27,801 - $31,848
-2,119 Reduced 10.59%
17,889 $251,000
Q1 2022

May 06, 2022
BUY
$13.54 - $15.35 $37,952 - $43,026
2,803 Added 16.29%
20,008 $287,000
Q4 2021

Feb 01, 2022
BUY
$13.17 - $16.4 $126,721 - $157,800
9,622 Added 126.89%
17,205 $235,000
Q3 2021

Nov 12, 2021
SELL
$16.3 - $17.26 $53,284 - $56,422
-3,269 Reduced 30.12%
7,583 $124,000
Q2 2021

Aug 09, 2021
BUY
$16.55 - $18.64 $6,222 - $7,008
376 Added 3.59%
10,852 $183,000
Q1 2021

May 12, 2021
BUY
$16.71 - $19.9 $18,865 - $22,467
1,129 Added 12.08%
10,476 $191,000
Q4 2020

Feb 16, 2021
SELL
$15.39 - $18.97 $32,488 - $40,045
-2,111 Reduced 18.42%
9,347 $170,000
Q3 2020

Nov 13, 2020
BUY
$17.1 - $19.19 $68,092 - $76,414
3,982 Added 53.26%
11,458 $204,000
Q2 2020

Aug 13, 2020
SELL
$14.59 - $19.5 $638,341 - $853,164
-43,752 Reduced 85.41%
7,476 $134,000
Q1 2020

May 15, 2020
SELL
$13.02 - $20.31 $10,962 - $17,101
-842 Reduced 1.62%
51,228 $779,000
Q4 2019

Feb 03, 2020
BUY
$16.88 - $20.83 $348,690 - $430,285
20,657 Added 65.76%
52,070 $1.01 Million
Q3 2019

Oct 24, 2019
BUY
$16.15 - $17.99 $4,489 - $5,001
278 Added 0.89%
31,413 $532,000
Q2 2019

Jul 24, 2019
BUY
$16.58 - $20.49 $116,905 - $144,474
7,051 Added 29.28%
31,135 $543,000
Q1 2019

Apr 29, 2019
BUY
$16.7 - $21.52 $182,731 - $235,471
10,942 Added 83.26%
24,084 $476,000
Q4 2018

Jan 17, 2019
BUY
$15.64 - $21.1 $172,994 - $233,387
11,061 Added 531.52%
13,142 $216,000
Q3 2018

Oct 29, 2018
SELL
$19.54 - $21.81 $3,908 - $4,362
-200 Reduced 8.77%
2,081 $37,000
Q2 2018

Aug 09, 2018
SELL
$18.98 - $24.95 $78,273 - $102,893
-4,124 Reduced 64.39%
2,281 $40,000
Q1 2018

May 10, 2018
SELL
$24.41 - $30.74 $1,025 - $1,291
-42 Reduced 0.65%
6,405 $149,000
Q4 2017

Jan 31, 2018
SELL
$26.96 - $28.56 $269 - $285
-10 Reduced 0.15%
6,447 $176,000
Q3 2017

Oct 13, 2017
BUY
$26.6 - $28.23 $11,571 - $12,280
435 Added 7.22%
6,457 $172,000
Q2 2017

Aug 15, 2017
BUY
N/A
6,022
6,022 $143,000

Others Institutions Holding TAK

# of Institutions
380
Shares Held
80.6M
Call Options Held
1.67M
Put Options Held
276K
View Full List

About TAKEDA PHARMACEUTICAL CO LTD

TAK Quotes by TradingView
  • Ticker TAK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 3,109,050,112
  • Market Cap $44.4B
  • Description
  • Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...
More about TAK
Track This Portfolio

Track Quadrant Capital Group LLC Portfolio

Follow Quadrant Capital Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quadrant Capital Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quadrant Capital Group LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email